Normal insulin secretion is oscillatory in vivo, and the oscillations are impaired in type II diabetes. We and others have shown oscillations in insulin secretion from isolated perifused islets stimulated with glucose, and in this study we show oscillations in insulin secretion from the glucose-sensitive clonal β-cell line INS-1. We have proposed that the oscillatory insulin secretion may be caused by spontaneous oscillations of glycolysis and the ATP:ADP ratio in the β-cell, analogous to those seen in glycolyzing muscle extracts. The mechanism of the latter involves autocatalytic activation of the key regulatory enzyme, phosphofructokinase (PFK), by its product fructose 1,6-bisphosphate (F16BP). However, of the three PFK subunit isoforms (M-[muscle], L-[liver], and C-type, predominant in fibroblasts), only M-type is activated by micromolar F16BP at near-physiological conditions. We therefore studied PFK isoforms in the β-cell. Western analysis of PFK subunits in isolated rat islets and INS-1 cells showed the presence of M-type, as well as C-type and perhaps lesser amounts of L-type. Kinetic studies of PFK activity in INS-1 cell extracts showed strong activation by micromolar concentrations of F16BP at near-physiological concentrations of ATP (several millimolar) and AMP and fructose 6-phosphate (micromolar), indicative of the M-type isoform. Activation by submicromolar concentrations of fructose 2,6-bisphosphate (F26BP) and potent inhibition by citrate were also observed. The F16BP-stimulatable activity was about one-half of the F26BP-stimulatable activity. These experiments demonstrate that μ-cells contain the M-type isoform of PFK with the requisite regulatory properties for generating glycolytic oscillations that may be the basis of oscillatory insulin secretion.
Skip Nav Destination
Article navigation
Original Articles|
November 01 1995
Phosphofructokinase Isozymes in Pancreatic Islets and Clonal β-Cells (INS-1)
Gordon C Yaney;
Gordon C Yaney
Diabetes and Metabolism Unit, Evans Department of Medicine Department of Biochemistry, Boston University School of Medicine
Boston, Massachusetts
Search for other works by this author on:
Vera Schultz;
Vera Schultz
Diabetes and Metabolism Unit, Evans Department of Medicine Department of Biochemistry, Boston University School of Medicine
Boston, Massachusetts
Search for other works by this author on:
Barbara A Cunningham;
Barbara A Cunningham
Diabetes and Metabolism Unit, Evans Department of Medicine Department of Biochemistry, Boston University School of Medicine
Boston, Massachusetts
Search for other works by this author on:
George A Dunaway;
George A Dunaway
Department of Pharmacology, Southern Dlinois University, School of Medicine
Springfield, Illinois
Diabetes and Metabolism Unit, Evans Department of Medicine Department of Biochemistry, Boston University School of Medicine
Boston, Massachusetts
Search for other works by this author on:
Barbara E Corkey;
Barbara E Corkey
Diabetes and Metabolism Unit, Evans Department of Medicine Department of Biochemistry, Boston University School of Medicine
Boston, Massachusetts
Search for other works by this author on:
Keith Tornheim
Keith Tornheim
Diabetes and Metabolism Unit, Evans Department of Medicine Department of Biochemistry, Boston University School of Medicine
Boston, Massachusetts
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Keith Tornheim, Boston University School of Medicine, 80 E. Concord St., E211, Boston, MA 02118
1
F16BP, fructose 1,6-bisphosphate; F26BP, fructose 2,6-bisphosphate; F6P, fructose 6-phosphate; G6P, glucose 6-phosphate; PFK, phosphofructokinase; PMSF, phenylmethylsulfonyl fluoride; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; TBS, Tris-buffered saline.
Diabetes 1995;44(11):1285–1289
Article history
Received:
May 10 1995
Revision Received:
July 20 1995
Accepted:
July 20 1995
PubMed:
7589825
Citation
Gordon C Yaney, Vera Schultz, Barbara A Cunningham, George A Dunaway, Barbara E Corkey, Keith Tornheim; Phosphofructokinase Isozymes in Pancreatic Islets and Clonal β-Cells (INS-1). Diabetes 1 November 1995; 44 (11): 1285–1289. https://doi.org/10.2337/diab.44.11.1285
Download citation file:
141
Views